Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Cardiovascular Medicine
Published in: Current Treatment Options in Cardiovascular Medicine 4/2010

01-08-2010 | Prevention

Obstructive Sleep Apnea and Cardiovascular Disease

Authors: David E. Green, MD, David A. Schulman, MD, MPH

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 4/2010

Login to get access

Opinion statement

Obstructive sleep apnea is a highly prevalent disease that often goes undetected for many years before diagnosis. Although most patients seek treatment to improve symptoms of daytime sleepiness, a growing body of literature suggests that treatment may also modulate cardiovascular risk. This article summarizes the current literature regarding the associations between sleep-disordered breathing and adverse cardiovascular outcomes and reviews the lesser body of data demonstrating the cardiovascular benefits of therapy.
Literature
1.
Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328(17):1230–1235.CrossRefPubMed
2.
Wright J, Johns R, Watt I, et al.: Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997, 314(7084):851–860.PubMed
3.
Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165(9):1217–1239.CrossRefPubMed
4.
Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 2000, 283(14):1829–1836.
5.
Peker Y, Carlson J, Hedner J: Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006, 28(3):596–602.CrossRefPubMed
6.
Gami AS, Hodge DO, Herges RM, et al.: Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49(5):565–571.CrossRefPubMed
7.
Mehra R, Benjamin EJ, Shahar E, et al.: Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173(8):910–916.CrossRefPubMed
8.
Arzt M, Young T, Finn L, et al.: Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172(11):1447–1451.CrossRefPubMed
9.
Kasai T, Narui K, Dohi T, et al.: Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008, 133(3):690–696.CrossRefPubMed
10.
Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046–1053.PubMed
11.•
Young T, Finn L, Peppard PE, et al.: Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31(8):1071–1078.PubMed
12.
Marshall NS, Wong KK, Liu PY, et al.: Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31(8):1079–1085.PubMed
13.
Bixler EO, Vgontzas AN, Lin HM, et al.: Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160(15):2289–2295.CrossRefPubMed
14.
Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378–1384.CrossRefPubMed
15.
Logan AG, Tkacova R, Perlikowski SM, et al.: Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21(2):241–247.CrossRefPubMed
16.
Alajmi M, Mulgrew AT, Fox J, et al.: Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185(2):67–72.CrossRefPubMed
17.
Haentjens P, Van Meerhaeghe A, Moscariello A, et al.: The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167(8):757–764.CrossRefPubMed
18.
19.
Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99(4):1592–1599.CrossRefPubMed
20.
O’Connor GT, Caffo B, Newman AB, et al.: Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179(12):1159–1164.CrossRefPubMed
21.
Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96(4):1897–1904.CrossRefPubMed
22.
Hla KM, Young T, Finn L, et al.: Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008, 31(6):795–800.PubMed
23.
Kato M, Roberts-Thomson P, Phillips BG, et al.: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102(21):2607–2610.PubMed
24.
Schafer H, Koehler U, Ploch T, Peter JH: Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997, 111(2):387–393.CrossRefPubMed
25.
Punjabi NM, Caffo BS, Goodwin JL, et al.: Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6(8):e1000132.CrossRefPubMed
26.
Sahlin C, Sandberg O, Gustafson Y, et al.: Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008, 168(3):297–301.CrossRefPubMed
27.
Peker Y, Kraiczi H, Hedner J, et al.: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14(1):179–184.CrossRefPubMed
28.
Shah NA, Yaggi HK, Concato J, Mohsenin V: Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 2009 Sep 24 (Epub ahead of print).
29.
Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352(12):1206–1214.CrossRefPubMed
30.
Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163(1):19–25.PubMed
31.
Valham F, Mooe T, Rabben T, et al.: Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 2008, 118(9):955–960.CrossRefPubMed
32.
Mooe T, Franklin KA, Holmstrom K, et al.: Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001, 164(10 Pt 1):1910–1913.PubMed
33.
Yaggi HK, Concato J, Kernan WN, et al.: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353(19):2034–2041.CrossRefPubMed
34.
Bassetti CL, Milanova M, Gugger M: Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006, 37(4):967–972.CrossRefPubMed
35.
Parra O, Arboix A, Bechich S, et al.: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161(2 Pt 1):375–380.PubMed
36.
Netzer N, Werner P, Jochums I, et al.: Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998, 29(1):87–93.PubMed
37.
Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105(21):2462–2464.CrossRefPubMed
38.
Sanner BM, Konermann M, Tepel M, et al.: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000, 16(4):648–652.CrossRefPubMed
39.
Oga T, Chin K, Tabuchi A, et al.: Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability. J Atheroscler Thromb 2009, 16(6):862–869.PubMed
40.
Ziegler MG, Nelesen R, Mills P, et al.: Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep 1997, 20(3):224–231.PubMed
41.
Larsson PT, Wallen NH, Egberg N, Hjemdahl P: Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992, 82(4):369–376.
42.
Reinhart WH, Oswald J, Walter R, Kuhn M: Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 2002, 27(3–4):201–207.PubMed
43.
Chin K, Ohi M, Kita H, et al.: Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 153(6 Pt 1):1972–1976.PubMed
44.•
Savransky V, Nanayakkara A, Li J, et al.: Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007, 175(12):1290–1297.CrossRefPubMed
45.
Ohga E, Nagase T, Tomita T, et al.: Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999, 87(1):10–14.PubMed
46.
Dyugovskaya L, Polyakov A, Lavie P, Lavie L: Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008, 177(5):544–554.CrossRefPubMed
47.
Ip MS, Lam B, Ng MM, et al.: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165(5):670–676.PubMed
48.
Olson LJ, Somers VK: Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007, 4(2):63–69.CrossRefPubMed
49.
Hanly P, Zuberi-Khokhar N: Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest 1995, 107(4):952–958.CrossRefPubMed
50.
Wang H, Parker JD, Newton GE, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49(15):1625–1631.CrossRefPubMed
51.
Javaheri S, Shukla R, Zeigler H, Wexler L: Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007, 49(20):2028–2034.CrossRefPubMed
52.
Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110(4):364–367.CrossRefPubMed
53.
Kanagala R, Murali NS, Friedman PA, et al.: Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107(20):2589–2594.PubMed
54.
Somers VK, Dyken ME, Mark AL, Abboud FM: Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension. Clin Auton Res 1992, 2(3):171–176.CrossRefPubMed
55.
Otto ME, Belohlavek M, Romero-Corral A, et al.: Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007, 99(9):1298–1302.CrossRefPubMed
56.
Sauer WH, McKernan ML, Lin D, et al.: Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006, 3(9):1024–1028.CrossRefPubMed
57.
Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al.: Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128(2):624–633.CrossRefPubMed
58.
Milleron O, Pilliere R, Foucher A, et al.: Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004, 25(9):728–734.CrossRefPubMed
59.
Drager LF, Bortolotto LA, Figueiredo AC, et al.: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176(7):706–712.CrossRefPubMed
60.
Hanly P, Sasson Z, Zuberi N, Lunn K: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993, 71(15):1341–1345.CrossRefPubMed
61.
Franklin KA, Nilsson JB, Sahlin C, Naslund U: Sleep apnoea and nocturnal angina. Lancet 1995, 345(8957):1085–1087.CrossRefPubMed
62.
Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348(13):1233–1241.PubMed
63.
Ryan CM, Usui K, Floras JS, Bradley TD: Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005, 60(9):781–785.CrossRefPubMed
64.
Usui K, Bradley TD, Spaak J, et al.: Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005, 45(12):2008–2011.CrossRefPubMed
65.
Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000, 101(4):392–397.PubMed
66.•
Khayat RN, Abraham WT, Patt B, et al.: In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest 2009, 136(4):991–997.CrossRefPubMed
67.
Pepperell JC, Maskell NA, Jones DR, et al.: A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168(9):1109–1114.CrossRefPubMed
68.
Teschler H, Dohring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164(4):614–619.PubMed
69.
Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107(1):68–73.CrossRefPubMed
70.
Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47(5):840–845.CrossRefPubMed
71.
Guilleminault C, Connolly SJ, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983, 52(5):490–494.CrossRefPubMed
Metadata
Title
Obstructive Sleep Apnea and Cardiovascular Disease
Authors
David E. Green, MD
David A. Schulman, MD, MPH
Publication date
01-08-2010
Publisher
Current Science Inc.
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 4/2010
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-010-0082-9

Other articles of this Issue 4/2010

Current Treatment Options in Cardiovascular Medicine 4/2010 Go to the issue

Prevention

Omega-3 Fatty Acids for Cardiovascular Disease Prevention

Prevention

Do We Know When and How to Lower Lipoprotein(a)?

Prevention

High-Density Lipoprotein Therapy: Is There Hope?

Prevention

Treatment of Angina and Microvascular Coronary Dysfunction

Prevention

Exercise as a Treatment for the Risk of Cardiovascular Disease

Prevention

Therapeutic Approaches to Obesity

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits